The vaccine, which protects against cervical cancer and sexually transmitted infections, does not do much to change …
The TV-show host responds to criticism that she sensationalized concerns over the HPV vaccine
Public-health officials may not have to worry so much about the low percentage of girls who don’t get all three doses of the human papillomavirus (HPV) vaccine.
In a small clinical trial, a therapeutic vaccine from Pennsylvania company Inovio Pharmaceuticals showed promise for treating precancerous cervical lesions in women with HPV.
A government task force recommends less frequent screening for cervical cancer and reverses its initial advice on HPV testing, allowing it for some women.
Confused about when or what cervical cancer screen you should get? A new study finds that HPV testing may benefit women over 30.
Our risk of cancer rises dramatically as we age — cancer is, after all, a disease of aging, a consequence of our increasing longevity. So it makes sense that the elderly should be routinely screened for new tumors — or doesn’t it?
If there is an upside to having gynecological cancer, it may involve bragging that your doctor is a rock star — and meaning it.
In 2009, a government advisory group sent women and their doctors into a frenzy when it rolled back recommendations for annual breast cancer screening for most women. Saying that routine mammograms could potentially do more harm …
This week we discuss cervical cancer, IUDs and the politicized debate over HPV vaccination. We also talk about whether gay men should be allowed to donate blood and why fathering a child depletes testosterone. Listen to this …
The IUD, or intrauterine device, is a highly effective method of birth control, and now a new study reveals that it may be useful in guarding against cervical cancer as well.
Monday night’s Republican primary debate saw candidate Michele Bachmann on the attack — especially against Texas Gov. Rick Perry. Bachmann slammed Perry for signing an executive order in 2007 requiring all sixth-grade girls to …
Two doses of the vaccine that protects against human papillomavirus (HPV) may be just as effective as the three-dose regimen that is currently recommended, according to the latest research from the National Cancer Institute (NCI).